Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder where misfolded alpha-synuclein-enriched aggregates called Lewy bodies are central in pathogenesis. No neuroprotective or disease-modifying treatments are currently available. Parkinson’s disease is considered a multifactorial disease and evid...

Full description

Bibliographic Details
Main Authors:	Johan Wallin, Per Svenningsson
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	International Journal of Molecular Sciences
Subjects:	montelukast alpha-synuclein leukotriene microglia neuroinflammation Parkinson’s disease
Online Access:	https://www.mdpi.com/1422-0067/22/11/5606

Similar Items

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
by: Johanna Michael, et al.
Published: (2021-03-01)

Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anticonvulsant properties
by: S.Yu. Shtrygol, et al.
Published: (2021-06-01)

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
by: Cátia F. Marques, et al.
Published: (2022-08-01)

Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope
by: Zhengying Wang, et al.
Published: (2023-11-01)

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
by: Alper Otunctemur, et al.
Published: (2015-04-01)

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
by: Eman El-Khateeb, et al.
Published: (2023-04-01)

Pediatric Asthma: Where Has Montelukast Gone?
by: Marco Maglione, et al.
Published: (2023-03-01)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
by: Ludwig Aigner, et al.
Published: (2020-12-01)

Effect of montelukast on leukotriene B4 metabolism in asthma
by: HU Yu, et al.
Published: (2023-05-01)

Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium
by: Yuan Li, et al.
Published: (2024-01-01)

A Double-Blind Non-inferiority Clinical Study of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Compared with Pranlukast in Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

The Efficacy of Montelukast Monotherapy in Moderate Persistent Asthmatic Children
by: Mahir Igde, et al.
Published: (2009-09-01)

Role of Leukotriene receptor antagonist Montelukast in the treatment of chronic urticaria: A hospital based study
by: Iffat Hassan, et al.
Published: (2012-01-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

Cysteinyl Leukotriene Pathway and Cancer
by: Ming-Ju Tsai, et al.
Published: (2021-12-01)

Montelukast and Acute Coronary Syndrome: The Endowed Drug
by: Basil Mohammed Alomair, et al.
Published: (2022-09-01)

Montelukast Use Decreases Cardiovascular Events in Asthmatics
by: Malvina Hoxha, et al.
Published: (2021-01-01)

Expert opinion on montelukast and acebrophylline combination in the management of asthma
by: N H Krishna, et al.
Published: (2021-01-01)

Leukotriene Signaling as a Target in α-Synucleinopathies
by: Katharina Strempfl, et al.
Published: (2022-02-01)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
by: Sang Bum Kim, et al.
Published: (2015-09-01)

Churg-Strauss Syndrome associated with montelukast: Three Case Reports
by: Fatih Yildiz, et al.
Published: (2014-04-01)

Theophylline and leukotriene modifiers: Is there any compelling role in COPD?
by: Abhijeet Singh, et al.
Published: (2020-01-01)

Montelukast and Coronavirus Disease 2019: A Scoping Review
by: Niusha Sharifinejad, et al.
Published: (2021-08-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)

Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men
by: Renata Esposito, et al.
Published: (2019-09-01)

Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
by: Bjørn Grinde, et al.
Published: (2017-08-01)

Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity
by: Margherita Tassan Mazzocco, et al.
Published: (2023-02-01)

Anti-leukotriene agents in modern therapy of bronchial asthma in children
by: Yu. L. Mizernitskiy
Published: (2020-03-01)

Cognitive Effects of Montelukast: A Pharmaco-EEG Study
by: Fabian Schwimmbeck, et al.
Published: (2021-04-01)

Montelukast ilişkili Churg Strauss Sendromu: Üç Olgu
by: Fatih YILDIZ, et al.
Published: (2014-07-01)

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
by: Elzbieta Janda, et al.
Published: (2018-04-01)

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
by: Anamaria Jurcau, et al.
Published: (2023-09-01)

Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: A double-blind, randomized clinical trial
by: Soleyman Heydari, et al.
Published: (2023-03-01)

The Mechanism and Function of Glia in Parkinson's Disease
by: Xinguo Zhang, et al.
Published: (2022-05-01)

Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice
by: J. Michael, et al.
Published: (2020-08-01)

Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
by: Murat Yarıktaş, et al.
Published: (2002-12-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain
by: Rachel Kelly, et al.
Published: (2022-01-01)

Editorial: Insights in inflammation pharmacology: 2022
by: Paola Patrignani, et al.
Published: (2023-06-01)